<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="CAD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>CA-3-M011474003</iati-identifier>
  <reporting-org ref="CA-3" type="10">
   <narrative xml:lang="FR">Affaires &#xE9;trang&#xE8;res, Commerce et D&#xE9;veloppement Canada (MAECD)</narrative>
   <narrative xml:lang="EN">Foreign Affairs, Trade and Development Canada (DFATD)</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Approvisionnement en m&#xE9;dicaments antituberculeux</narrative>
   <narrative xml:lang="EN">Global Drug Facility: Provision of Anti-Tuberculosis Drugs</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Cette subvention repr&#xE9;sente une partie de la contribution du Canada au Dispositif mondial pour l&apos;approvisionnement en m&#xE9;dicaments, un programme du Partenariat Halte &#xE0; la tuberculose. Il fournit des m&#xE9;dicaments antituberculeux aux gouvernements qui acceptent d&#x2019;instaurer, d&#x2019;&#xE9;tendre ou de maintenir les politiques de diagnostic, de traitement et de suivi dans le cadre de la strat&#xE9;gie DOTS (traitement de br&#xE8;ve dur&#xE9;e sous surveillance directe). Lanc&#xE9; en 2001, le Dispositif vise &#xE0; mieux approvisionner en m&#xE9;dicaments ainsi qu&apos;&#xE0; am&#xE9;liorer leur distribution et suivi dans les pays en d&#xE9;veloppement. Il est le seul fournisseur au monde &#xE0; acheter des m&#xE9;dicaments antituberculeux en grandes quantit&#xE9;s. Le Canada &#xE9;tait le donateur fondateur du Dispositif et jusqu&apos;en 2010 il est le principal pays donateur pour les m&#xE9;dicaments antituberculeux de premi&#xE8;re ligne depuis la fondation du Dispositif en 2001.  Le Dispositif mondial pour l&apos;approvisionnement en m&#xE9;dicaments est un m&#xE9;canisme en quatre volets : 1) les pays qui n&#x2019;ont pas les moyens d&#x2019;acheter tous les m&#xE9;dicaments antituberculeux dont ils ont besoin peuvent demander des m&#xE9;dicaments subventionn&#xE9;s pour une p&#xE9;riode d&#x2019;au plus six ans &#x2013; le MAECD finance ce volet; 2) les pays qui ont les moyens d&#x2019;acheter tous les m&#xE9;dicaments antituberculeux dont ils ont besoin mais qui ne peuvent pas garantir leur qualit&#xE9; peuvent acheter ces m&#xE9;dicaments par l&#x2019;interm&#xE9;diaire du Dispositif, et ce, &#xE0; un prix inf&#xE9;rieur (prix d&apos;achat en masse) &#x2013; le MAECD ne finance pas ce volet; 3) les pays dot&#xE9;s d&#x2019;un syst&#xE8;me d&#x2019;approvisionnement d&#xE9;ficient peuvent recevoir un appui technique pour renforcer leurs capacit&#xE9;s au chapitre de l&#x2019;approvisionnement en m&#xE9;dicaments &#x2013; le MAECD finance ce volet; 4) les pays b&#xE9;n&#xE9;ficiaires du Fonds mondial peuvent s&#x2019;approvisionner directement en m&#xE9;dicaments antituberculeux par l&#x2019;interm&#xE9;diaire du Dispositif (en utilisant les sommes vers&#xE9;es par le Fonds mondial), de fa&#xE7;on &#xE0; s&#x2019;assurer un approvisionnement stable de m&#xE9;dicaments de haute qualit&#xE9;.</narrative>
   <narrative xml:lang="EN">This grant represents part of Canada&#x2019;s contribution to the Global Drug Facility (GDF), a program of the Stop TB Partnership. It provides access to anti-tuberculosis (TB) drugs for governments that agree to introduce, expand, or maintain the diagnostic, treatment, and monitoring policies of the DOTS (directly observed treatment, short-term) strategy. Launched in 2001, the GDF works to improve the supply, distribution, and monitoring of anti-TB drugs in developing countries and is the only global bulk procurer of anti-TB drugs. Canada was the founding donor of the GDF and to date (2010) has been the single largest donor country for first-line TB drugs.  The GDF is a four-pronged mechanism whereby: (1) countries who cannot afford to procure all the anti-TB drug they need are eligible to apply for drugs for up to six years (DFATD provides funding for this component); (2) countries who can pay for the anti-TB drugs they need but cannot assure the quality of the drugs can directly procure them through the GDF at reduced bulk prices (DFATD funding does not contribute to this component); (3) countries where the procurement system is weak can receive technical assistance to strengthen their capacity for drug procurement (DFATD supports this component); and (4) Global Fund recipient countries can procure anti-TB drugs directly through GDF, using Global Fund monies, to ensure a stable and high-quality drug supply.</narrative>
  </description>
  <participating-org ref="CA" role="1" type="10">
   <narrative xml:lang="EN">Canada</narrative>
   <narrative xml:lang="FR">Canada</narrative>
  </participating-org>
  <participating-org ref="CA-1" role="3" type="10">
   <narrative xml:lang="FR">Agence canadienne de d&#xE9;veloppement international</narrative>
   <narrative xml:lang="EN">Canadian International Development Agency</narrative>
  </participating-org>
  <participating-org crs-channel-code="41502" ref="XM-DAC-41502" role="4" type="40">
   <narrative xml:lang="EN">United Nations Office for ProjectServices: Stop TB Partnership</narrative>
   <narrative xml:lang="FR">United Nations Office for ProjectServices: Stop TB Partnership</narrative>
  </participating-org>
  <other-identifier ref="2017202002" type="A2"></other-identifier>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2010-03-20" type="2"></activity-date>
  <activity-date iso-date="2017-12-29" type="3"></activity-date>
  <activity-date iso-date="2020-02-11" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Affaires &#xE9;trang&#xE8;res, Commerce et D&#xE9;veloppement Canada (MAECD)</narrative>
    <narrative xml:lang="EN">Foreign Affairs, Trade and Development Canada (DFATD)</narrative>
   </organisation>
   <email>info@international.gc.ca</email>
   <website>www.international.gc.ca</website>
   <mailing-address>
    <narrative xml:lang="EN">125 Sussex Drive, Ottawa, Ontario, K1A 0G2</narrative>
    <narrative xml:lang="FR">125, promenade Sussex, Ottawa (Ontario), K1A 0G2</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="298" percentage="35" vocabulary="1"></recipient-region>
  <recipient-region code="498" percentage="1" vocabulary="1"></recipient-region>
  <recipient-region code="798" percentage="61" vocabulary="1"></recipient-region>
  <recipient-region code="89" percentage="3" vocabulary="1"></recipient-region>
  <sector code="12263" percentage="100" vocabulary="1"></sector>
  <policy-marker code="10" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">Adolescent (Youth) Issues</narrative>
   <narrative xml:lang="FR">Questions touchant les adolescents (jeunes)</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">Children&apos;s issues</narrative>
   <narrative xml:lang="FR">Questions touchant les enfants</narrative>
  </policy-marker>
  <policy-marker code="13" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">ICT as a tool for development</narrative>
   <narrative xml:lang="FR">Les TIC comme outils de d&#xE9;veloppement</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">Indigenous issues</narrative>
   <narrative xml:lang="FR">Questions touchant les populations autochtones</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="FR">Questions urbaines</narrative>
   <narrative xml:lang="EN">Urban issues</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="B03" vocabulary="1"></default-aid-type>
  <budget status="2" type="1">
   <period-start iso-date="2008-04-01"></period-start>
   <period-end iso-date="2009-03-31"></period-end>
   <value currency="CAD" value-date="2010-03-20">37121095</value>
  </budget>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2008-12-23"></transaction-date>
   <value currency="CAD" value-date="2008-12-23">6000000</value>
   <receiver-org ref="XM-DAC-41502"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2009-03-31"></transaction-date>
   <value currency="CAD" value-date="2009-03-31">1800000</value>
   <receiver-org ref="XM-DAC-41502"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2010-03-26"></transaction-date>
   <value currency="CAD" value-date="2010-03-26">7000000</value>
   <receiver-org ref="XM-DAC-41502"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2011-03-18"></transaction-date>
   <value currency="CAD" value-date="2011-03-18">13000000</value>
   <receiver-org ref="XM-DAC-41502"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2011-12-06"></transaction-date>
   <value currency="CAD" value-date="2011-12-06">7000000</value>
   <receiver-org ref="XM-DAC-41502"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2012-03-22"></transaction-date>
   <value currency="CAD" value-date="2012-03-22">2321095</value>
   <receiver-org ref="XM-DAC-41502"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2010-03-20"></transaction-date>
   <value currency="CAD" value-date="2010-03-20">37121095.01</value>
   <flow-type code="10"></flow-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <document-link format="TEXT/HTML" url="http://w05.international.gc.ca/projectbrowser-banqueprojets/project-projet/details/M011474003?Lang=eng">
   <title>
    <narrative xml:lang="EN">Description</narrative>
   </title>
   <category code="A02"></category>
   <category code="A08"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="http://w05.international.gc.ca/projectbrowser-banqueprojets/project-projet/details/M011474003?Lang=fra">
   <title>
    <narrative xml:lang="FR">Description</narrative>
   </title>
   <category code="A02"></category>
   <category code="A08"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://search.open.canada.ca/en/gc/?sort=score%20desc&amp;page=1&amp;search_text=M011474003">
   <title>
    <narrative xml:lang="FR">Proactive disclosure</narrative>
   </title>
   <category code="A06"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://rechercher.ouvert.canada.ca/fr/gc/?sort=score desc&amp;page=1&amp;search_text=M011474003">
   <title>
    <narrative xml:lang="FR">Divulgation proactive</narrative>
   </title>
   <category code="A06"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.stoptb.org">
   <title>
    <narrative xml:lang="EN">Activity website</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <conditions attached="0"></conditions>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Results achieved</narrative>
    <narrative xml:lang="FR">R&#xE9;sultats atteints</narrative>
   </title>
   <indicator measure="5">
    <title>
     <narrative xml:lang="EN">Results achieved</narrative>
     <narrative xml:lang="FR">R&#xE9;sultats atteints</narrative>
    </title>
    <description>
     <narrative xml:lang="FR">En date de mars 2016, le Dispositif mondial pour l&apos;approvisionnement en m&#xE9;dicaments avait obtenu les r&#xE9;sultats suivants gr&#xE2;ce au soutien du gouvernement du Canada et d&#x2019;autres donateurs &#xE9;trangers : 1) des traitements de qualit&#xE9; garantie ont &#xE9;t&#xE9; fournis depuis 2001 &#xE0; plus de 27 millions de patients atteints de tuberculose (TB), dont plus de 184 000 traitements de la tuberculose multi-r&#xE9;sistante et 1,5 million de traitements administr&#xE9;s &#xE0; des enfants; 2) plus de 1,5 million de traitements ont &#xE9;t&#xE9; fournis, dont plus de 219 000 traitements &#xE0; des enfants en 2015; 3) un soutien au renforcement des capacit&#xE9;s a &#xE9;t&#xE9; fourni &#xE0; 134 pays depuis 2001, entre autres sous la forme de formations et d&#x2019;ateliers ainsi que de missions de suivi et d&#x2019;assistance technique pour am&#xE9;liorer la gestion des approvisionnements en m&#xE9;dicaments; 4) le projet a contribu&#xE9; &#xE0; la planification et &#xE0; la r&#xE9;alisation de l&#x2019;introduction &#xE0; l&#x2019;&#xE9;chelle mondiale de nouveaux m&#xE9;dicaments adapt&#xE9;s aux enfants pour soigner la TB de l&#x2019;enfant; 5) le projet a mis &#xE0; la disposition des pays un m&#xE9;canisme qui leur permet de commander les nouvelles pr&#xE9;parations pour enfants et offre des subventions aux pays admissibles pour l&#x2019;achat de m&#xE9;dicaments antituberculeux pour enfants gr&#xE2;ce au financement d&#x2019;Affaires mondiales Canada.</narrative>
     <narrative xml:lang="EN">Results achieved by Global Drug Facility, through the support of the Government of Canada and other international donors, as of March 2016 include: (1) provided quality-assured treatments since 2001 for more than 27 million patients with tuberculosis (TB), This included over 184,000 patient treatments for multi-drug resistant TB (MDR-TB) and 1.5 million treatments for children; (2) delivered over 1.5 million patient treatments, including over 219,000 pediatric treatments in 2015; (3) provided capacity-building support to 134 countries since 2001, including training and workshops, monitoring missions and technical assistance to improve the management of drug supplies; (4) contributed to planning and guidance for the global introduction of new child-friendly medicines for pediatric TB; and (5) provided a mechanism for countries to order the new pediatric formulations and made grants available to eligible countries to purchase pediatric TB medicines with funding from Global Affairs Canada.</narrative>
    </description>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
